138 related articles for article (PubMed ID: 3067339)
1. Olsalazine in the treatment of active ulcerative colitis: a placebo controlled clinical trial and assessment of drug disposition.
Hetzel DJ; Shearman DJ; Labrooy J; Bochner F; Imhoff DM; Gibson GE; Fitch RJ; Hecker R; Rowland R
Scand J Gastroenterol Suppl; 1988; 148():61-9. PubMed ID: 3067339
[TBL] [Abstract][Full Text] [Related]
2. Treatment of ulcerative colitis with olsalazine and sulphasalazine: efficacy and side-effects.
Ewe K; Eckardt V; Kanzler G
Scand J Gastroenterol Suppl; 1988; 148():70-5. PubMed ID: 2906479
[TBL] [Abstract][Full Text] [Related]
3. Olsalazine in the treatment of mild to moderate ulcerative colitis: a randomized, placebo-controlled, double-blind, clinical trial.
Feurle GE; Theuer D; Velasco S; Barry BA; Wördehoff D; Sommer A; Jantschegk Y; Kruis W
Scand J Gastroenterol Suppl; 1988; 148():38-9. PubMed ID: 3067338
[TBL] [Abstract][Full Text] [Related]
4. Double-blind comparison of olsalazine and sulphasalazine in active ulcerative colitis.
Willoughby CP; Cowan RE; Gould SR; Machell RJ; Stewart JB
Scand J Gastroenterol Suppl; 1988; 148():40-4. PubMed ID: 2906476
[TBL] [Abstract][Full Text] [Related]
5. Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial.
Meyers S; Sachar DB; Present DH; Janowitz HD
Gastroenterology; 1987 Dec; 93(6):1255-62. PubMed ID: 2890550
[TBL] [Abstract][Full Text] [Related]
6. Olsalazine in the treatment of ulcerative colitis among patients intolerant of sulphasalazine: a prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial.
Meyers S; Sachar DB; Present DH; Janowitz HD
Scand J Gastroenterol Suppl; 1988; 148():29-37. PubMed ID: 2906474
[TBL] [Abstract][Full Text] [Related]
7. Olsalazine versus placebo in the treatment of mild to moderate ulcerative colitis: a randomised double blind trial.
Feurle GE; Theuer D; Velasco S; Barry BA; Wördehoff D; Sommer A; Jantschek G; Kruis W
Gut; 1989 Oct; 30(10):1354-61. PubMed ID: 2684804
[TBL] [Abstract][Full Text] [Related]
8. Controlled trial comparing olsalazine and sulphasalazine for maintenance treatment of ulcerative colitis.
Jewell DP; Ireland A
Scand J Gastroenterol Suppl; 1988; 148():45-7. PubMed ID: 2906477
[TBL] [Abstract][Full Text] [Related]
9. Olsalazine in active ulcerative colitis.
Selby WS; Barr GD; Ireland A; Mason CH; Jewell DP
Br Med J (Clin Res Ed); 1985 Nov; 291(6506):1373-5. PubMed ID: 3933675
[TBL] [Abstract][Full Text] [Related]
10. Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study.
Rao SS; Dundas SA; Holdsworth CD; Cann PA; Palmer KR; Corbett CL
Gut; 1989 May; 30(5):675-9. PubMed ID: 2567266
[TBL] [Abstract][Full Text] [Related]
11. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
Segars LW; Gales BJ
Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685
[TBL] [Abstract][Full Text] [Related]
12. Double-blind placebo-controlled study of olsalazine in the treatment of ulcerative colitis.
Zinberg J; Molinas S; Das KM
Am J Gastroenterol; 1990 May; 85(5):562-6. PubMed ID: 2337059
[TBL] [Abstract][Full Text] [Related]
13. Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis.
Kruis W; Brandes JW; Schreiber S; Theuer D; Krakamp B; Schütz E; Otto P; Lorenz-Mayer H; Ewe K; Judmaier G
Aliment Pharmacol Ther; 1998 Aug; 12(8):707-15. PubMed ID: 9726382
[TBL] [Abstract][Full Text] [Related]
14. Olsalazine versus sulphasalazine for relapse prevention in ulcerative colitis: a multicenter study.
Nilsson A; Danielsson A; Löfberg R; Benno P; Bergman L; Fausa O; Florholmen J; Karvonen AL; Kildebo S; Kollberg B
Am J Gastroenterol; 1995 Mar; 90(3):381-7. PubMed ID: 7872274
[TBL] [Abstract][Full Text] [Related]
15. 5-Aminosalicylic acid enemas in treatment of distal ulcerative colitis and proctitis in Canada.
Sutherland LR; Martin F
Dig Dis Sci; 1987 Dec; 32(12 Suppl):64S-66S. PubMed ID: 3319459
[TBL] [Abstract][Full Text] [Related]
16. Double-blind dose-finding study of olsalazine versus sulphasalazine as maintenance therapy for ulcerative colitis.
Kruis W; Judmaier G; Kayasseh L; Stolte M; Theuer D; Scheurlen C; Hentschel E; Kratochvil P
Eur J Gastroenterol Hepatol; 1995 May; 7(5):391-6. PubMed ID: 7614099
[TBL] [Abstract][Full Text] [Related]
17. Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis.
Ireland A; Mason CH; Jewell DP
Gut; 1988 Jun; 29(6):835-7. PubMed ID: 2898422
[TBL] [Abstract][Full Text] [Related]
18. Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse.
Riley SA; Mani V; Goodman MJ; Herd ME; Dutt S; Turnberg LA
Gut; 1988 May; 29(5):669-74. PubMed ID: 2899536
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic effects of olsalazine v sulphasalazine during 12 months maintenance treatment of ulcerative colitis. The Danish Olsalazine Study Group.
Kiilerich S; Ladefoged K; Rannem T; Ranløv PJ
Gut; 1992 Feb; 33(2):252-5. PubMed ID: 1347280
[TBL] [Abstract][Full Text] [Related]
20. Treatment of left-sided ulcerative colitis with 4-aminosalicylic acid enemas. A double-blind, placebo-controlled trial.
Ginsberg AL; Beck LS; McIntosh TM; Nochomovitz LE
Ann Intern Med; 1988 Feb; 108(2):195-9. PubMed ID: 3277506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
